Atomic Pharmaceutics was founded in 2020 and has created the first beverage that allows the delivery of over-the-counter anti-inflammatories such as Aspirin and/or Acetaminophen in a tasty, pleasant, and easy-to-ingest functional beverage.
If you are an individual interested in investing in Atomic Pharmaceutics, it’s your lucky day because we are currently running a crowdfunding campaign through Broota to raise capital for Atomic. This will enable us to proceed through two of the four steps we have designed to navigate the FDA Internal Analgesic Temporary Final Monograph.